Cencora
About: Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Employees: 46,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
83% more first-time investments, than exits
New positions opened: 168 | Existing positions closed: 92
59% more call options, than puts
Call options by funds: $1.37B | Put options by funds: $863M
7% more capital invested
Capital invested by funds: $51.5B [Q1] → $55.1B (+$3.63B) [Q2]
4% more funds holding
Funds holding: 1,276 [Q1] → 1,326 (+50) [Q2]
5% more repeat investments, than reductions
Existing positions increased: 493 | Existing positions reduced: 468
0.52% less ownership
Funds ownership: 95.49% [Q1] → 94.96% (-0.52%) [Q2]
22% less funds holding in top 10
Funds holding in top 10: 27 [Q1] → 21 (-6) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
|
Wells Fargo
Stephen Baxter
|
$354
|
Overweight
Maintained
|
13 Aug 2025 |
|
Morgan Stanley
Erin Wright
|
$330
|
Equal-Weight
Maintained
|
16 Jul 2025 |
|
Jefferies
Jonathan Petersen
|
$300
|
Hold
Maintained
|
30 Jun 2025 |
Financial journalist opinion
Based on 9 articles about COR published over the past 30 days
